The current study aimed to examine the effect of depressive and anxiety symptoms on physical and psychological quality of life (QOL) in end‐stage renal disease patient‐family caregiver dyads using the Actor‐Partner Interdependence Model. This was a descriptive cross‐sectional study. Dyads' (N = 120) symptoms of anxiety and depression and QOL were assessed via the Hospital Anxiety and Depression Scale and the World Health Organization (WHO)QOL‐BREF, respectively. The depression scores were higher (worse) in patients than in caregivers (8.74 ± 5.23 vs. 6.9 ± 3.9, t[df 119] = 3.339, p = .001). Patients had lower (worse) scores on the physical domain of QOL than the caregivers (47.37 ± 22.9 vs. 64.1 ± 17.49, t[df 119] = −7.165, p < .001). Anxiety and depressive symptoms exhibited actor effects on the physical and psychological QOL of the dyad. Only depressive symptoms in caregivers exhibited a partner effect on the psychological domain of QOL in patients (β = −.745, p < .05). In conclusion, anxiety and depressive symptoms in both patients and caretakers are equally crucial in end‐stage renal disease management.
Purpose To determine whether somatic or cognitive depressive symptoms affect hospitalization and death in patients with end‐stage renal disease. Design and Method In an observational retrospective design, the patients (n = 190) completed the Beck Depression Inventory‐II at baseline and were followed for 5 years to collect data all‐cause mortality and hospitalization. Findings High somatic (53.7%, n = 102) and cognitive (52.1%, n = 99) depressive symptoms scores significantly associated with mortality (38% vs. 19%; hazard ratio [HR] = 2; 95% CI, 1.1–3.7; p = 0.02) and hospitalization (62.5% vs. 49.4%; HR = 1.6; 95% CI, 1.0–2.6; p = 0.03), respectively. Practice Implications In the context of diagnosing and intervening, awareness of depressive symptoms dimensionality is crucial.
20 September 2023 in Journal of Cardiovascular Nursing
Background: Limited knowledge exists regarding patients' denial of myocardial infarction (MI) before hospitalization for an MI. Objective: The aim of this study was to determine the prevalence and correlates of denial of MI in the prehospital phase of a confirmed MI. Methods: This secondary analysis included 166 hospitalized patients (mean [SD] age, 54.1 [10.5] years) who developed MI outside a healthcare facility and had high congruence between their experienced and expected symptoms. Measurements included the Denial subscale of the Brief COPE Inventory, the modified Response to Symptoms Questionnaire, and a Likert scale measuring perceived risk for MI. Patients who arrived at a hospital at least 1 hour after the onset of their symptoms were considered to have prolonged prehospital delay. Results: Despite their high symptom congruence, 77% of patients denied the possibility of having an MI before hospitalization. The lower denial group was characterized by cardiac history, whereas the higher denial group was distinguished by nonsmoking, a lower perceived risk of MI, less anxiety at symptom onset, and more concerns about seeking medical help. Compared with the lower denial group, patients in the higher denial group were more likely to underestimate the seriousness of their symptoms and delay seeking medical help. The higher denial group responded to symptoms in a more passive manner (eg, waiting), whereas the lower denial group showed a more problem-solving approach (eg, contacting emergency services). Conclusions: Denial of MI is highly prevalent in the prehospital phase and is negatively linked with cognitive, emotional, and behavioral responses to MI symptoms.